Ascletis Pharma (ASCLF) Projected to Post Quarterly Earnings on Tuesday

Chronological Source Flow
Back

AI Fusion Summary

Ascletis Pharma (ASCLF) is expected to report a quarterly loss of $0.04 per share on March 31, with the stock trading near $1.81. The clinical‑stage Chinese biopharma focuses on viral and liver disease therapies.
24/03 17:24 defenseworld.net
3 Πηγές
24/03 17:35 defenseworld.net
24/03 17:35 defenseworld.net
Comments
Loading...
0